A group of Fudan Univ. has shown in vitro that the FDA-approved drugs (Protoporphyrin IX (PpIX), Verteporfin) effectively inhibit the infection of SARS-CoV-2.
This is because these compounds bind to ACE2, inhibiting the binding of SARS-CoV-2 to ACE2.
Clinical trials in vivo are expected.
https://www.sciencedirect.com/science/article/pii/S2095927320307283?via%3Dihub
